With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The World Health Organization's (WHO) chief hit back Monday at United States (US) President Donald Trump's reasons for ...

The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...